Trade

Vivanza Biosciences share price

High risk
  • 47%Low risk
  • 47%Moderate risk
  • 47%Balanced risk
  • 47%High risk
  • 47%Extreme risk
  • 1.97(-1.50%)
    March 6, 2026 15:15:00 PM IST
    • NSE
    • BSE
  • Vol : 23.97 K (NSE + BSE)
    Last 20 day avg : 19.89 K

Vivanza Biosciences is trading -1.50% lower at Rs 1.97 as compared to its last closing price. Vivanza Biosciences has been trading in the price range of 1.97 & 1.96. Vivanza Biosciences has given -9.09% in this year & -1.96% in the last 5 days. The company posted a net profit of 0.20 Crores in its last quarter.Listed peers of Vivanza Biosciences include Sun Pharmaceutical Industries (0.68%), Divi's Laboratories (-1.76%), Torrent Pharmaceuticals (-0.87%).The Mutual Fund holding in Vivanza Biosciences was at -% in . The MF holding has - from the last quarter. The FII holding in Vivanza Biosciences was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Mar 08, 2026, 05:16 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -0.17
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1.96
Highest
1.97
52 week range
Lowest
1.90
Highest
2.94
Vivanza Biosciences Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,795.000.684,31,372.1335.985.730.960.50
Divi's Laboratories
Bearish
6,251.20-1.761,65,988.8476.0311.140.480.01
Torrent Pharmaceuticals
Bullish
4,315.35-0.871,46,045.1973.9318.770.8317.62
Cipla
Bearish
1,321.75-0.321,06,800.6320.703.490.960.81
Dr Reddy's Laboratories
Bullish
1,304.80-0.631,09,403.2218.843.180.622.34
Vivanza Biosciences Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-12Quarterly Results
2025-11-11Quarterly Results
2025-09-01Others
2025-08-13Quarterly Results
2025-05-12Audited Results
About the company Vivanza Biosciences
  • IndustryBiotechnology & Drugs
  • ISININE984E01035
  • BSE Code530057
  • NSE Code
Vivanza Biosciences Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of pharmaceutical products. Its products include gloves and surgical. Its Gloves products include latex examination gloves powdered, latex surgical powder free, latex free examination gloves-vinyl, latex free examination gloves-nitrile, and latex surgical powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves, Therapeutic Index Injection, Veterinary Product, and Veterinary Feed. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.
  • Management Info
  • Jainil BhattChief Financial Officer
  • Jayendra MehtaManaging Director, Executive Director
Vivanza Biosciences Share Price FAQs

Vivanza Biosciences is trading at 1.97 as on Fri Mar 06 2026 09:45:00. This is -1.50% lower as compared to its previous closing price of 2.00.

The market capitalization of Vivanza Biosciences is 7.88 Cr as on Fri Mar 06 2026 09:45:00.

The 52 wk high for Vivanza Biosciences is 2.94 whereas the 52 wk low is 1.90

Vivanza Biosciences can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: -

Vivanza Biosciences reported a net profit of -0.67 Cr in 2025.